Founded in 1847, Thuasne® designs, develops and manufactures medical devices allowing everyone to become actors in their own health. For 6 generations, the Group has been offering solutions to prevent and treat conditions in the fields of orthopedics, medical compression and sport.
Thuasne invests €4m in france to develop a digitalized dynamic compression post-cancer solution
Thuasne®, a global and European player in medical compression devices, announces that it is investing €4 million in Saint-Étienne (France) to develop a digitalized dynamic compression solution integrating motorized pressure on the limb.
Objective: to help improve the management of post-cancer lymphedema, a chronic condition that affects nearly 250 million people worldwide.
The project, carried out in a territorial consortium with the Jean Monnet University of Saint-Étienne, is supported by the French State, the Auvergne-Rhône-Alpes Region and Bpifrance as part of the regionalized I-Démo program (France 2030).
We
act to restore mobility and improve quality of life
For over 175 years, Thuasne® has been developing recognized expertise in textiles. This expertise is put to use in the service of health, to treat and prevent conditions in the fields of orthopedics, medical compression and sports.
Every day, the Group's researchers innovate and design original medical devices, combining therapeutic efficacy, comfort and compliance to support patients and healthcare professionals.
Every day, our 2,500 passionate employees design healthcare solutions that push back the limits of movement.
Joining Thuasne® means growing within an international group on a human scale, where your expertise actively contributes to improving the daily lives of millions of patients around the world.
In 1847, in northern France, the company that would later become Thuasne® was founded. Present on five continents, the Group now markets innovative non-invasive healthcare solutions for mobility.
06.03.2026 Lymphedema: a disease that is still too little known
